Xencor, Inc APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Xencor, Inc (XNCR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $9.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $9.19M, a 14.39% decline year-over-year.
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $9.56M, a 21.71% decline year-over-year.
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $10.09M, a 18.20% decline year-over-year.
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $10.74M, a 37.54% decline year-over-year.
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $43.23M, a 18.87% decline from fiscal 2024.
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $53.28M, a 0.88% decline from fiscal 2023.
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $53.76M, a 9.90% increase from fiscal 2022.
- Xencor, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $48.91M, a 32.29% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.19M 10-Q · filed 2026-08-05 | $18.75M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $9.56M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $43.23M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $10.09M 10-Q · filed 2025-11-05 | $20.83M derived: sum of 2 quarters · filed 2026-08-05 | $33.04M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $10.74M 10-Q · filed 2026-08-05 | $22.95M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $12.21M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $53.28M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $12.34M 10-Q · filed 2025-11-05 | $29.53M derived: sum of 2 quarters · filed 2025-11-05 | $40.95M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $17.19M 10-Q · filed 2025-11-05 | $28.61M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $11.42M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $53.76M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $12.90M 10-Q/A · filed 2025-02-24 | $26.46M derived: sum of 2 quarters · filed 2025-02-24 | $39.06M derived: sum of 3 quarters · filed 2025-02-24 | |
| 2023-06-30 | $13.56M 10-Q/A · filed 2025-02-24 | $26.16M derived: sum of 2 quarters · filed 2025-02-24 | ||
| 2023-03-31 | $12.60M 10-Q/A · filed 2025-02-24 | |||
| 2022-12-31 | $48.91M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $12.76M 10-Q · filed 2023-11-08 | $25.36M derived: sum of 2 quarters · filed 2023-11-08 | $36.17M derived: sum of 3 quarters · filed 2023-11-08 | |
| 2022-06-30 | $12.60M 10-Q · filed 2023-11-08 | $23.41M derived: sum of 2 quarters · filed 2023-11-08 | ||
| 2022-03-31 | $10.80M 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $36.98M 10-K/A · filed 2025-02-24 | |||
| 2021-09-30 | $8.94M 10-Q · filed 2022-11-07 | $18.29M derived: sum of 2 quarters · filed 2022-11-07 | $26.59M derived: sum of 3 quarters · filed 2022-11-07 | |
| 2021-06-30 | $9.35M 10-Q · filed 2022-11-07 | $17.64M derived: sum of 2 quarters · filed 2022-11-07 | ||
| 2021-03-31 | $8.29M 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | $31.62M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $8.32M 10-Q · filed 2021-11-08 | $16.55M derived: sum of 2 quarters · filed 2021-11-08 | $23.06M derived: sum of 3 quarters · filed 2021-11-08 | |
| 2020-06-30 | $8.23M 10-Q · filed 2021-11-08 | $14.74M derived: sum of 2 quarters · filed 2021-11-08 | ||
| 2020-03-31 | $6.51M 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | $31.85M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $9.51M 10-Q · filed 2020-11-06 | $18.82M derived: sum of 2 quarters · filed 2020-11-06 | $24.67M derived: sum of 3 quarters · filed 2020-11-06 | $29.75M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $9.30M 10-Q · filed 2020-11-06 | $15.16M derived: sum of 2 quarters · filed 2020-11-06 | $20.23M derived: sum of 3 quarters · filed 2021-02-24 | $26.35M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $5.86M 10-Q · filed 2020-11-06 | $10.93M derived: sum of 2 quarters · filed 2021-02-24 | $17.05M derived: sum of 3 quarters · filed 2021-02-24 | $21.93M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $11.20M derived: sum of 2 quarters · filed 2021-02-24 | $16.08M derived: sum of 3 quarters · filed 2021-02-24 | $20.55M 10-K · filed 2021-02-24 |
| 2018-09-30 | $6.12M 10-Q · filed 2019-11-05 | $11.00M derived: sum of 2 quarters · filed 2019-11-05 | $15.47M 10-Q · filed 2018-11-05 | $18.91M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $4.88M 10-Q · filed 2019-11-05 | $9.35M 10-Q · filed 2018-08-07 | $12.79M derived: sum of 3 quarters · filed 2020-02-25 | $16.40M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $4.47M 10-Q · filed 2019-11-05 | $7.91M derived: sum of 2 quarters · filed 2020-02-25 | $11.52M derived: sum of 3 quarters · filed 2020-02-25 | $14.96M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.04M derived: sum of 2 quarters · filed 2020-02-25 | $10.49M derived: sum of 3 quarters · filed 2020-02-25 | $13.65M 10-K · filed 2020-02-25 |
| 2017-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $7.05M derived: sum of 2 quarters · filed 2017-11-08 | $10.21M 10-Q · filed 2017-11-08 | $12.20M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $6.61M 10-Q · filed 2017-08-07 | $8.60M derived: sum of 3 quarters · filed 2019-02-26 | $10.46M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $3.16M 10-Q · filed 2017-05-10 | $5.15M derived: sum of 2 quarters · filed 2019-02-26 | $7.01M derived: sum of 3 quarters · filed 2019-02-26 | $9.05M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.85M derived: sum of 2 quarters · filed 2019-02-26 | $5.89M derived: sum of 3 quarters · filed 2019-02-26 | $7.85M 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $3.90M derived: sum of 2 quarters · filed 2016-11-02 | $5.86M 10-Q · filed 2016-11-02 | $7.34M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $3.99M 10-Q · filed 2016-08-03 | $5.48M derived: sum of 3 quarters · filed 2018-02-28 | $6.56M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $1.96M 10-Q · filed 2016-05-02 | $3.44M derived: sum of 2 quarters · filed 2018-02-28 | $4.53M derived: sum of 3 quarters · filed 2018-02-28 | $5.72M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.57M derived: sum of 2 quarters · filed 2018-02-28 | $3.76M derived: sum of 3 quarters · filed 2018-02-28 | $4.87M 10-K · filed 2018-02-28 |
| 2015-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $2.28M derived: sum of 2 quarters · filed 2015-11-04 | $3.39M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $2.30M 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | $1.11M 10-Q · filed 2015-05-05 | |||
| 2014-12-31 | $1.86M 10-K · filed 2017-03-01 | |||
| 2013-12-31 | $198.00K 10-K · filed 2016-03-08 | |||
| 2012-12-31 | $29.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |